Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
Critical limb ischemia: a global epidemic.A critical analysis of current treatment unmasks the clinical and economic costs of CLI.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Khan MH, Khan MA, Fail PS, Vivekananthan K, Mitran EV, Allie SE, Chaisson G, Stagg SJ, Allie AA, McElderry MW, Walker CM.
PMID: 19758881
EuroIntervention. 2005 May;1(1):75-84.

BACKGROUND: Multiple reports document the higher costs of primary amputation (PA) compared to infrainguinal bypass surgery (IBS). Recent reports document 40-50% cost-effectiveness for percutaneous transluminal angioplasty (PTA) compared to IBS. The literature suggests appropriate initial treatment for critical limb...

Cite
Allie DE, Hebert CJ, Lirtzman MD, et al. Critical limb ischemia: a global epidemic.A critical analysis of current treatment unmasks the clinical and economic costs of CLI. EuroIntervention. 2005;1(1):75-84
Allie, D. E., Hebert, C. J., Lirtzman, M. D., Wyatt, C. H., Keller, V. A., Khan, M. H., Khan, M. A., Fail, P. S., Vivekananthan, K., Mitran, E. V., Allie, S. E., Chaisson, G., Stagg, S. J., Allie, A. A., McElderry, M. W., & Walker, C. M. (2005). Critical limb ischemia: a global epidemic.A critical analysis of current treatment unmasks the clinical and economic costs of CLI. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 1(1), 75-84.
Allie, David E, et al. "Critical limb ischemia: a global epidemic.A critical analysis of current treatment unmasks the clinical and economic costs of CLI." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 1,1 (2005): 75-84.
Allie DE, Hebert CJ, Lirtzman MD, Wyatt CH, Keller VA, Khan MH, Khan MA, Fail PS, Vivekananthan K, Mitran EV, Allie SE, Chaisson G, Stagg SJ, Allie AA, McElderry MW, Walker CM. Critical limb ischemia: a global epidemic.A critical analysis of current treatment unmasks the clinical and economic costs of CLI. EuroIntervention. 2005 May;1(1):75-84. PMID: 19758881.
Copy Download .nbib Format: NLM
Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.

Nature cell biology

Okada T, Sinha S, Esposito I, Schiavon G, López-Lago MA, Su W, Pratilas CA, Abele C, Hernandez JM, Ohara M, Okada M, Viale A, Heguy A, Socci ND, Sapino A, Seshan VE, Long S, Inghirami G, Rosen N, Giancotti FG.
PMID: 30842593
Nat Cell Biol. 2019 Apr;21(4):534. doi: 10.1038/s41556-019-0288-3.

In the version of this Article originally published the same blot was inadvertently presented as both p-Rb and Cyclin A in Fig. 2a. This blot corresponds to the p-Rb panel, as can be seen in the unprocessed version of...

Cite
Okada T, Sinha S, Esposito I, et al. Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling. Nat Cell Biol. 2019;21(4):534doi: 10.1038/s41556-019-0288-3.
Okada, T., Sinha, S., Esposito, I., Schiavon, G., López-Lago, M. A., Su, W., Pratilas, C. A., Abele, C., Hernandez, J. M., Ohara, M., Okada, M., Viale, A., Heguy, A., Socci, N. D., Sapino, A., Seshan, V. E., Long, S., Inghirami, G., Rosen, N., & Giancotti, F. G. (2019). Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling. Nature cell biology, 21(4), 534. https://doi.org/10.1038/s41556-019-0288-3
Okada, Tomoyo, et al. "Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling." Nature cell biology vol. 21,4 (2019): 534. doi: https://doi.org/10.1038/s41556-019-0288-3
Okada T, Sinha S, Esposito I, Schiavon G, López-Lago MA, Su W, Pratilas CA, Abele C, Hernandez JM, Ohara M, Okada M, Viale A, Heguy A, Socci ND, Sapino A, Seshan VE, Long S, Inghirami G, Rosen N, Giancotti FG. Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling. Nat Cell Biol. 2019 Apr;21(4):534. doi: 10.1038/s41556-019-0288-3. PMID: 30842593.
Copy Download .nbib Format: NLM
Outcomes of Chronic Turf Toe Repair in Non-athlete Population: A Retrospective Study.

Indian journal of orthopaedics

Pinter ZW, Farnell CG, Huntley S, Patel HA, Peng J, McMurtrie J, Ray JL, Naranje S, Shah AB.
PMID: 32211128
Indian J Orthop. 2020 Jan 13;54(1):43-48. doi: 10.1007/s43465-019-00010-8. eCollection 2020 Feb.

BACKGROUND: Turf toe injuries, though most common in athletes, can also occur in non-athletes. No study exists in the current literature investigating operative outcomes in non-athlete patients with chronic turf toe injury. In this study, we present our outcomes...

Cite
Pinter ZW, Farnell CG, Huntley S, et al. Outcomes of Chronic Turf Toe Repair in Non-athlete Population: A Retrospective Study. Indian J Orthop. 2020;54(1):43-48doi: 10.1007/s43465-019-00010-8.
Pinter, Z. W., Farnell, C. G., Huntley, S., Patel, H. A., Peng, J., McMurtrie, J., Ray, J. L., Naranje, S., & Shah, A. B. (2020). Outcomes of Chronic Turf Toe Repair in Non-athlete Population: A Retrospective Study. Indian journal of orthopaedics, 54(1), 43-48. https://doi.org/10.1007/s43465-019-00010-8
Pinter, Zachariah W, et al. "Outcomes of Chronic Turf Toe Repair in Non-athlete Population: A Retrospective Study." Indian journal of orthopaedics vol. 54,1 (2020): 43-48. doi: https://doi.org/10.1007/s43465-019-00010-8
Pinter ZW, Farnell CG, Huntley S, Patel HA, Peng J, McMurtrie J, Ray JL, Naranje S, Shah AB. Outcomes of Chronic Turf Toe Repair in Non-athlete Population: A Retrospective Study. Indian J Orthop. 2020 Jan 13;54(1):43-48. doi: 10.1007/s43465-019-00010-8. eCollection 2020 Feb. PMID: 32211128; PMCID: PMC7065733.
Copy Download .nbib Format: NLM
Vascularized fibular grafts for the treatment of long bone defects: pros and cons. A systematic review and meta-analysis.

Archives of orthopaedic and trauma surgery

Feltri P, Solaro L, Errani C, Schiavon G, Candrian C, Filardo G.
PMID: 34110477
Arch Orthop Trauma Surg. 2021 Jun 10; doi: 10.1007/s00402-021-03962-5. Epub 2021 Jun 10.

PURPOSE: To quantify union rate, complication rate, reintervention rate, as well as functional outcome after vascularized fibular bone grafts (VFGs) for the treatment of long-bone defects.METHODS: A comprehensive search was performed in the PubMed, Web of Science, and Cochrane...

Cite
Feltri P, Solaro L, Errani C, et al. Vascularized fibular grafts for the treatment of long bone defects: pros and cons. A systematic review and meta-analysis. Arch Orthop Trauma Surg. 2021;doi: 10.1007/s00402-021-03962-5.
Feltri, P., Solaro, L., Errani, C., Schiavon, G., Candrian, C., & Filardo, G. (2021). Vascularized fibular grafts for the treatment of long bone defects: pros and cons. A systematic review and meta-analysis. Archives of orthopaedic and trauma surgery, . https://doi.org/10.1007/s00402-021-03962-5
Feltri, Pietro, et al. "Vascularized fibular grafts for the treatment of long bone defects: pros and cons. A systematic review and meta-analysis." Archives of orthopaedic and trauma surgery vol. (2021). doi: https://doi.org/10.1007/s00402-021-03962-5
Feltri P, Solaro L, Errani C, Schiavon G, Candrian C, Filardo G. Vascularized fibular grafts for the treatment of long bone defects: pros and cons. A systematic review and meta-analysis. Arch Orthop Trauma Surg. 2021 Jun 10; doi: 10.1007/s00402-021-03962-5. Epub 2021 Jun 10. PMID: 34110477.
Copy Download .nbib Format: NLM
Children with Developmental Disabilities in Low- and Middle-Income Countries: More Neglected and Physically Punished.

International journal of environmental research and public health

Bizzego A, Lim M, Schiavon G, Esposito G.
PMID: 32992729
Int J Environ Res Public Health. 2020 Sep 25;17(19). doi: 10.3390/ijerph17197009.

Little is known about parenting in the context of developmental disabilities in low- and middle-income countries (LMIC), penalized by both lack of data and a research bias toward western societies. In this study, we apply data mining methods on...

Cite
Bizzego A, Lim M, Schiavon G, et al. Children with Developmental Disabilities in Low- and Middle-Income Countries: More Neglected and Physically Punished. Int J Environ Res Public Health. 2020;17(19)doi: 10.3390/ijerph17197009.
Bizzego, A., Lim, M., Schiavon, G., & Esposito, G. (2020). Children with Developmental Disabilities in Low- and Middle-Income Countries: More Neglected and Physically Punished. International journal of environmental research and public health, 17(19), . https://doi.org/10.3390/ijerph17197009
Bizzego, Andrea, et al. "Children with Developmental Disabilities in Low- and Middle-Income Countries: More Neglected and Physically Punished." International journal of environmental research and public health vol. 17,19 (2020). doi: https://doi.org/10.3390/ijerph17197009
Bizzego A, Lim M, Schiavon G, Esposito G. Children with Developmental Disabilities in Low- and Middle-Income Countries: More Neglected and Physically Punished. Int J Environ Res Public Health. 2020 Sep 25;17(19). doi: 10.3390/ijerph17197009. PMID: 32992729; PMCID: PMC7579206.
Copy Download .nbib Format: NLM
Interoperable Open Specifications Framework for the Implementation of Standardized Urban Platforms.

Sensors (Basel, Switzerland)

Hernández JL, García R, Schonowski J, Atlan D, Chanson G, Ruohomäki T.
PMID: 32340252
Sensors (Basel). 2020 Apr 23;20(8). doi: 10.3390/s20082402.

The current cities' urban challenges go through digitalization and integration of new technologies under the perspective of actual and future ecological, as well as socio-economic commitments. This process is translated into the Open Standardized Urban Data Platform, which plays...

Cite
Hernández JL, García R, Schonowski J, et al. Interoperable Open Specifications Framework for the Implementation of Standardized Urban Platforms. Sensors (Basel). 2020;20(8)doi: 10.3390/s20082402.
Hernández, J. L., García, R., Schonowski, J., Atlan, D., Chanson, G., & Ruohomäki, T. (2020). Interoperable Open Specifications Framework for the Implementation of Standardized Urban Platforms. Sensors (Basel, Switzerland), 20(8), . https://doi.org/10.3390/s20082402
Hernández, José L, et al. "Interoperable Open Specifications Framework for the Implementation of Standardized Urban Platforms." Sensors (Basel, Switzerland) vol. 20,8 (2020). doi: https://doi.org/10.3390/s20082402
Hernández JL, García R, Schonowski J, Atlan D, Chanson G, Ruohomäki T. Interoperable Open Specifications Framework for the Implementation of Standardized Urban Platforms. Sensors (Basel). 2020 Apr 23;20(8). doi: 10.3390/s20082402. PMID: 32340252; PMCID: PMC7219583.
Copy Download .nbib Format: NLM
Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection.

Molecular oncology

Cani AK, Dolce EM, Darga EP, Hu K, Liu CJ, Pierce J, Bradbury K, Kilgour E, Aung K, Schiavon G, Carroll D, Carr TH, Klinowska T, Lindemann J, Marshall G, Rowlands V, Harrington EA, Barrett JC, Sathiyayogan N, Morrow C, Sero V, Armstrong AC, Baird R, Hamilton E, Im SA, Jhaveri K, Patel MR, Dive C, Tomlins SA, Udager AM, Hayes DF, Paoletti C.
PMID: 34866317
Mol Oncol. 2021 Dec 06; doi: 10.1002/1878-0261.13150. Epub 2021 Dec 06.

Nearly all estrogen receptor (ER)-positive (POS) metastatic breast cancers become refractory to endocrine (ET) and other therapies, leading to lethal disease presumably due to evolving genomic alterations. Timely monitoring of the molecular events associated with response/progression by serial tissue...

Cite
Cani AK, Dolce EM, Darga EP, et al. Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection. Mol Oncol. 2021;doi: 10.1002/1878-0261.13150.
Cani, A. K., Dolce, E. M., Darga, E. P., Hu, K., Liu, C. J., Pierce, J., Bradbury, K., Kilgour, E., Aung, K., Schiavon, G., Carroll, D., Carr, T. H., Klinowska, T., Lindemann, J., Marshall, G., Rowlands, V., Harrington, E. A., Barrett, J. C., Sathiyayogan, N., Morrow, C., Sero, V., Armstrong, A. C., Baird, R., Hamilton, E., Im, S. A., Jhaveri, K., Patel, M. R., Dive, C., Tomlins, S. A., Udager, A. M., Hayes, D. F., & Paoletti, C. (2021). Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection. Molecular oncology, . https://doi.org/10.1002/1878-0261.13150
Cani, Andi K, et al. "Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection." Molecular oncology vol. (2021). doi: https://doi.org/10.1002/1878-0261.13150
Cani AK, Dolce EM, Darga EP, Hu K, Liu CJ, Pierce J, Bradbury K, Kilgour E, Aung K, Schiavon G, Carroll D, Carr TH, Klinowska T, Lindemann J, Marshall G, Rowlands V, Harrington EA, Barrett JC, Sathiyayogan N, Morrow C, Sero V, Armstrong AC, Baird R, Hamilton E, Im SA, Jhaveri K, Patel MR, Dive C, Tomlins SA, Udager AM, Hayes DF, Paoletti C. Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection. Mol Oncol. 2021 Dec 06; doi: 10.1002/1878-0261.13150. Epub 2021 Dec 06. PMID: 34866317.
Copy Download .nbib Format: NLM
Infrared Thermography for the Evaluation of Inflammatory and Degenerative Joint Diseases: A Systematic Review.

Cartilage

Schiavon G, Capone G, Frize M, Zaffagnini S, Candrian C, Filardo G.
PMID: 34933442
Cartilage. 2021 Dec;13(2):1790S-1801S. doi: 10.1177/19476035211063862.

OBJECTIVE: Inflammation plays a central role in the pathophysiology of rheumatic diseases as well as in osteoarthritis. Temperature, which can be quantified using infrared thermography, provides information about the inflammatory component of joint diseases. This systematic review aims at...

Cite
Schiavon G, Capone G, Frize M, et al. Infrared Thermography for the Evaluation of Inflammatory and Degenerative Joint Diseases: A Systematic Review. Cartilage. 2021;13(2):1790S-1801Sdoi: 10.1177/19476035211063862.
Schiavon, G., Capone, G., Frize, M., Zaffagnini, S., Candrian, C., & Filardo, G. (2021). Infrared Thermography for the Evaluation of Inflammatory and Degenerative Joint Diseases: A Systematic Review. Cartilage, 13(2), 1790S-1801S. https://doi.org/10.1177/19476035211063862
Schiavon, Guglielmo, et al. "Infrared Thermography for the Evaluation of Inflammatory and Degenerative Joint Diseases: A Systematic Review." Cartilage vol. 13,2 (2021): 1790S-1801S. doi: https://doi.org/10.1177/19476035211063862
Schiavon G, Capone G, Frize M, Zaffagnini S, Candrian C, Filardo G. Infrared Thermography for the Evaluation of Inflammatory and Degenerative Joint Diseases: A Systematic Review. Cartilage. 2021 Dec;13(2):1790S-1801S. doi: 10.1177/19476035211063862. PMID: 34933442.
Copy Download .nbib Format: NLM
Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study.

JCO precision oncology

Smyth LM, Reichel JB, Tang J, Patel JAA, Meng F, Selcuklu DS, Houck-Loomis B, You D, Samoila A, Schiavon G, Li BT, Razavi P, Piscuoglio S, Reis-Filho JS, Taylor BS, Baselga J, Solit DB, Hyman DM, Berger MF, Chandarlapaty S.
PMID: 34250397
JCO Precis Oncol. 2021 Jan 08;5. doi: 10.1200/PO.20.00184. eCollection 2021.

PURPOSE: Cell-free DNA (cfDNA) analysis offers a noninvasive means to access the tumor genome. Despite limited sensitivity of broad-panel sequencing for detecting low-frequency mutations in cfDNA, it may enable more comprehensive genomic characterization in patients with sufficiently high disease...

Cite
Smyth LM, Reichel JB, Tang J, et al. Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study. JCO Precis Oncol. 2021;5doi: 10.1200/PO.20.00184.
Smyth, L. M., Reichel, J. B., Tang, J., Patel, J. A. A., Meng, F., Selcuklu, D. S., Houck-Loomis, B., You, D., Samoila, A., Schiavon, G., Li, B. T., Razavi, P., Piscuoglio, S., Reis-Filho, J. S., Taylor, B. S., Baselga, J., Solit, D. B., Hyman, D. M., Berger, M. F., & Chandarlapaty, S. (2021). Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study. JCO precision oncology, 5. https://doi.org/10.1200/PO.20.00184
Smyth, Lillian M, et al. "Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study." JCO precision oncology vol. 5 (2021). doi: https://doi.org/10.1200/PO.20.00184
Smyth LM, Reichel JB, Tang J, Patel JAA, Meng F, Selcuklu DS, Houck-Loomis B, You D, Samoila A, Schiavon G, Li BT, Razavi P, Piscuoglio S, Reis-Filho JS, Taylor BS, Baselga J, Solit DB, Hyman DM, Berger MF, Chandarlapaty S. Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study. JCO Precis Oncol. 2021 Jan 08;5. doi: 10.1200/PO.20.00184. eCollection 2021. PMID: 34250397; PMCID: PMC8232437.
Copy Download .nbib Format: NLM
Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study.

JCO precision oncology

Smyth LM, Reichel JB, Tang J, Patel JAA, Meng F, Selcuklu DS, Houck-Loomis B, You D, Samoila A, Schiavon G, Li BT, Razavi P, Piscuoglio S, Reis-Filho JS, Taylor BS, Baselga J, Solit DB, Hyman DM, Berger MF, Chandarlapaty S.
PMID: 34250397
JCO Precis Oncol. 2021 Jan 08;5. doi: 10.1200/PO.20.00184. eCollection 2021.

PURPOSE: Cell-free DNA (cfDNA) analysis offers a noninvasive means to access the tumor genome. Despite limited sensitivity of broad-panel sequencing for detecting low-frequency mutations in cfDNA, it may enable more comprehensive genomic characterization in patients with sufficiently high disease...

Cite
Smyth LM, Reichel JB, Tang J, et al. Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study. JCO Precis Oncol. 2021;5doi: 10.1200/PO.20.00184.
Smyth, L. M., Reichel, J. B., Tang, J., Patel, J. A. A., Meng, F., Selcuklu, D. S., Houck-Loomis, B., You, D., Samoila, A., Schiavon, G., Li, B. T., Razavi, P., Piscuoglio, S., Reis-Filho, J. S., Taylor, B. S., Baselga, J., Solit, D. B., Hyman, D. M., Berger, M. F., & Chandarlapaty, S. (2021). Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study. JCO precision oncology, 5. https://doi.org/10.1200/PO.20.00184
Smyth, Lillian M, et al. "Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study." JCO precision oncology vol. 5 (2021). doi: https://doi.org/10.1200/PO.20.00184
Smyth LM, Reichel JB, Tang J, Patel JAA, Meng F, Selcuklu DS, Houck-Loomis B, You D, Samoila A, Schiavon G, Li BT, Razavi P, Piscuoglio S, Reis-Filho JS, Taylor BS, Baselga J, Solit DB, Hyman DM, Berger MF, Chandarlapaty S. Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study. JCO Precis Oncol. 2021 Jan 08;5. doi: 10.1200/PO.20.00184. eCollection 2021. PMID: 34250397; PMCID: PMC8232437.
Copy Download .nbib Format: NLM
Porous electrodes supported on ion-exchange membranes as electrochemical detectors for supercritical fluid chromatography.

Analytical chemistry

Toniolo R, Comisso N, Schiavon G, Bontempelli G.
PMID: 15053680
Anal Chem. 2004 Apr 01;76(7):2133-7. doi: 10.1021/ac0351421.

A conveniently assembled electrochemical cell, exploiting a porous electrode supported on a moist perfluorinated ion-exchange polymer, is proposed for profitable electrochemical detection in supercritical fluid chromatography. It consists of a porous Pt working electrode, contacted by the mobile phase...

Cite
Toniolo R, Comisso N, Schiavon G, et al. Porous electrodes supported on ion-exchange membranes as electrochemical detectors for supercritical fluid chromatography. Anal Chem. 2004;76(7):2133-7doi: 10.1021/ac0351421.
Toniolo, R., Comisso, N., Schiavon, G., & Bontempelli, G. (2004). Porous electrodes supported on ion-exchange membranes as electrochemical detectors for supercritical fluid chromatography. Analytical chemistry, 76(7), 2133-7. https://doi.org/10.1021/ac0351421
Toniolo, Rosanna, et al. "Porous electrodes supported on ion-exchange membranes as electrochemical detectors for supercritical fluid chromatography." Analytical chemistry vol. 76,7 (2004): 2133-7. doi: https://doi.org/10.1021/ac0351421
Toniolo R, Comisso N, Schiavon G, Bontempelli G. Porous electrodes supported on ion-exchange membranes as electrochemical detectors for supercritical fluid chromatography. Anal Chem. 2004 Apr 01;76(7):2133-7. doi: 10.1021/ac0351421. PMID: 15053680.
Copy Download .nbib Format: NLM
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?.

Annals of oncology : official journal of the European Society for Medical Oncology

Santini D, Vincenzi B, Addeo R, Garufi C, Masi G, Scartozzi M, Mancuso A, Frezza AM, Venditti O, Imperatori M, Schiavon G, Bronte G, Cicero G, Recine F, Maiello E, Cascinu S, Russo A, Falcone A, Tonini G.
PMID: 28327895
Ann Oncol. 2017 Nov 01;28(11):2906. doi: 10.1093/annonc/mdw551.

No abstract available.

Cite
Santini D, Vincenzi B, Addeo R, et al. Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?. Ann Oncol. 2017;28(11):2906doi: 10.1093/annonc/mdw551.
Santini, D., Vincenzi, B., Addeo, R., Garufi, C., Masi, G., Scartozzi, M., Mancuso, A., Frezza, A. M., Venditti, O., Imperatori, M., Schiavon, G., Bronte, G., Cicero, G., Recine, F., Maiello, E., Cascinu, S., Russo, A., Falcone, A., & Tonini, G. (2017). Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?. Annals of oncology : official journal of the European Society for Medical Oncology, 28(11), 2906. https://doi.org/10.1093/annonc/mdw551
Santini, D, et al. "Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?." Annals of oncology : official journal of the European Society for Medical Oncology vol. 28,11 (2017): 2906. doi: https://doi.org/10.1093/annonc/mdw551
Santini D, Vincenzi B, Addeo R, Garufi C, Masi G, Scartozzi M, Mancuso A, Frezza AM, Venditti O, Imperatori M, Schiavon G, Bronte G, Cicero G, Recine F, Maiello E, Cascinu S, Russo A, Falcone A, Tonini G. Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?. Ann Oncol. 2017 Nov 01;28(11):2906. doi: 10.1093/annonc/mdw551. PMID: 28327895.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries